Obeticholic Acid Tablets In Stock
Liver Disease

Obeticholic Acid Tablets

Obeticholic Acid Tablets is a farnesoid X receptor (FXR) agonist used for the management of certain cholestatic liver diseases, including primary biliary cholangitis (PBC), under specialist medical supervision.

Product Details

Obeticholic Acid Tablets contains obeticholic acid, a farnesoid X receptor (FXR) agonist used in the management of certain chronic liver conditions involving impaired bile flow. It is primarily associated with the treatment of primary biliary cholangitis (PBC) in appropriate patients and works by influencing bile acid production and transport pathways.

Key Benefits
- Used in the management of primary biliary cholangitis (PBC) in appropriate patients
- Helps regulate bile acid metabolism
- Supports management of cholestatic liver disease
- May help reduce markers of liver injury in suitable patients
- Provides targeted activity through FXR activation
How It Works
Obeticholic acid activates the farnesoid X receptor (FXR), a receptor involved in the regulation of bile acid synthesis, transport, and metabolism. FXR activation can reduce excessive bile acid production and influence pathways involved in liver inflammation and cholestasis.
Common Side Effects
- Itching
- Fatigue
- Abdominal discomfort
- Nausea
- Headache
- Joint pain
- Dizziness
Important Information
Obeticholic Acid Tablets should be used only under the supervision of a qualified hepatologist or healthcare professional. The medicine may cause or worsen severe liver-related complications in certain patients, particularly those with advanced or decompensated liver disease. Liver function should be assessed and monitored during treatment. Inform your healthcare professional about all medicines you are taking and any history of liver disease, bile duct obstruction, or other relevant conditions. Seek immediate medical attention if jaundice, severe abdominal pain, significant swelling, confusion, or other signs of worsening liver function occur.